Raytheon requires U.S. workers get COVID-19 vaccination
Reuters
Published Sep 15, 2021 04:35PM ET
Updated Sep 15, 2021 05:05PM ET
By Mike Stone
WASHINGTON (Reuters) -Raytheon, the maker of Tomahawk missiles, will require all U.S. employees to have a COVID-19 vaccination, the company said in a Wednesday statement.
The employees need to get shots by mid-December in order to meet a Jan. 1 deadline for immunization, a source familiar with policy said.
"In keeping with our ongoing commitment to maintain employee health and safety, Raytheon Technologies (NYSE:RTX) will require its U.S. employees to be fully vaccinated to further protect employees and communities from the risks and uncertainty of COVID-19 and its variants," the statement said.
"The expectation is that employees meet the requirement and if they do not, like any company policy, there are levels of disciplinary action that could be considered - up to and including termination," the person familiar with policy said.
Raytheon (NYSE:RTN) has 181,000 employees around the world but only U.S. employees are subject to the policy.
U.S. President Joe Biden met on Wednesday with U.S. CEOs and other top business leaders as he pushes companies to require workers to be inoculated against COVID-19 amid a surge in infections among the unvaccinated.
Biden last week announced vaccine mandates for nearly all federal employees, federal contractors, and larger companies as the number of U.S. infections continued to rise, hospital beds in some parts of the country filled up and mask requirements returned.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.